← brief for 2026-09-29 · Slowing decline

Safety and Efficacy of Finerenone in Diabetic Kidney Disease: A Single-Center Retrospective Real-World Comparative Study of Dosing and Clinical Decision-Making in Taiwan

Article C Peer reviewed Observational

Key takeaways

This study compared 100 people with diabetic kidney disease. Half took a drug called finerenone, and half did not. The drug group had less protein in their urine. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Jui-Ting Hsu (Chang Gung University) · Pei-Chen Tseng (Chang Gung University) · Lung‐Chih Li (Chang Gung University) · Terry Ting‐Yu Chiou (Chang Gung University) · Chien-Hua Chiu (Chang Gung University) · Po-Yen Kuo (Chang Gung University) · Chiang-Chi Huang (Chang Gung University) · Kai‐Fan Tsai (Chang Gung University) · Tsuen-Wei Hsu (Chang Gung University) · Po-Jung Wu (Chang Gung University) · Yueh‐Ting Lee (Chang Gung University) · Chien‐Te Lee (Chang Gung University)

Source

Article · OpenAlex, CKD works · 2026-09-28
https://doi.org/10.3390/ph19101539